Reproductive endocrinology

The Influence of Trinucleotide Repeats in the Androgen Receptor Gene on Androgen-related Traits and Diseases

J Clin Endocrinol MetabPublished Cross-sectional genetic association study

Authors' conclusion

In this large-scale study, we found that longer CAG and GGC repeats in the AR gene influence androgen resistance, elevate circulating testosterone level via a feedback loop, and play a role in some androgen-targeted tissues. Generally, however, circulating testosterone level is a more important determinant of androgen action in males than repeat lengths.

Study context

Population
European-ancestry male participants in the UK Biobank
Participants
181,217 males
Exposure
Androgen receptor (AR) gene CAG and GGC repeat lengths vs androgen-related traits and diseases
Outcome
Associations of AR CAG and GGC repeat lengths with androgen-related traits and diseases
Methodological detailspopulation-based, UK Biobank, whole-genome and whole-exome sequencing, Repeat lengths quantified with ExpansionHunter
  • Population-based
  • UK Biobank
  • Whole-genome and whole-exome sequencing
  • Repeat lengths quantified with ExpansionHunter

Main finding

As reported in the abstract

  • Both repeat lengths positively associated with circulating total testosterone and BMD
  • CAG repeat length negatively associated with male-pattern baldness
  • Effects relatively small; no association with most other outcomes

Observational data: associations, not effects.

Further findings

Total testosterone and outcomes, adjusted for repeat lengths

Total testosterone associated with various outcomes; relationship not affected by adjustment for repeat lengths

Original publication

The Influence of Trinucleotide Repeats in the Androgen Receptor Gene on Androgen-related Traits and Diseases. J Clin Endocrinol Metab. Published 3 May 2024. doi:10.1210/clinem/dgae302

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.